Lysergic Acid Diethylamide (LSD-25) as a Facilitating Agent in Psychotherapy
Archives of General Psychiatry March 1, 1960 DOI: 10.1001/archpsyc.1960.03590090042008 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Study Peer reviewed |
|---|---|
| Intervention | LSD-25 |
| Topics | LSD Mescaline Psilocybin |
| Keywords | Psychotherapist Hallucinogen Pharmacology |
| Citations | 77 |
| Key points | LSD-25 and similar drugs can broaden awareness and help patients access repressed material in psychotherapy. |
Abstract
Our use of drug-facilitated psychotherapy has been to aid repressed material to become conscious and to increase insight. Any method or tool which facilitates these processes has the possibility of being a valuable psychotherapeutic tool. Certain drugs on which we have done research, such as mescaline, ALD-52, ibogaine, psilocybin, Ditran (N-ethyl-3-piperidyl cyclopentylphenyl glycolate HC1), and lysergic acid diethylamide (LSD-25), have the capacity to broaden the patient’s spectrum of awareness. If a patient uses this enhanced capacity to look inward, he is often enabled, particularly in the case of LSD-25, to see and experience many affects, childhood memories, conflicts, and impulse strivings which were previously blotted out by the repressive forces. The present study was conducted in an attempt further to evaluate the use of LSD-25 as an aid to psychotherapy and to develop procedures and techniques for its most effective utilization with